Scott A. Halperin

Treatment of severe pertussis: a study of the safety and pharmacology of intravenous pertussis immunoglobulin.

M. Dhalla, R. Malley, G. Siber, 1999, The Pediatric infectious disease journal.

Tdap vaccine in pregnancy and immunogenicity of pertussis and pneumococcal vaccines in children: What is the impact of different immunization schedules?

N. Brousseau, Y. Febriani, Thowiba Mansour, 2023, Vaccine.

Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age.

S. Halperin, E. Mills, B. Eastwood, 1995, The Pediatric infectious disease journal.

Infection of Newborn Piglets with Bordetella pertussis: a New Model for Pertussis

L. Babiuk, S. Elahi, V. Gerdts, 2005, Infection and Immunity.

An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults.

D. Skowronski, S. Halperin, Bruce Smith, 2000, Vaccine.

Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study

A. Galvani, S. Moghadas, A. Shoukat, 2023, Lancet regional health. Americas.

Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.

S. Halperin, J. King, E. Mills, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines.

K. Edwards, M. Decker, S. Halperin, 1992, The Journal of pediatrics.

An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) study.

Brian Ward, Bruce Smith, L. Ye, 2023, Vaccine.

Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age.

S. Halperin, D. Scheifele, B. Eastwood, 1999, The Pediatric infectious disease journal.